Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.69 USD
Change Today +0.045 / 7.03%
Volume 187.7K
CYCC On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 4:00 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at cyclacel pharmaceuticals inc (CYCC)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Spiro Rombotis 38 RelationshipsChief Executive Officer, President and Executive DirectorChief Executive Officer56
Paul McBarron 13 RelationshipsChief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Finance & Administration, Secretary and Executive DirectorChief Financial Officer54

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
David U'Prichard Ph.D. 156 RelationshipsChairman of the BoardDruid Consulting, LLC66
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 75 RelationshipsVice ChairmanOncothyreon Inc74
John Banham DL, MA, HonLLD, HonDSc 80 RelationshipsMember of the Board of DirectorsCyclacel Pharmaceuticals, Inc.74
Nicholas Bacopoulos Ph.D. 14 RelationshipsMember of the Board of DirectorsKotinos Pharmaceuticals, Inc.66
Enrico Mihich M.D. 13 RelationshipsMember of Advisory BoardCyclacel Pharmaceuticals, Inc.--
Michel Marty M.D. 37 RelationshipsMember of Advisory BoardInvivis Pharmaceuticals Inc.--
Karol Sikora MA (Cantab) MBBCh Ph.D.(Cantab) FRCR FRCP FFPM 91 RelationshipsMember of Advisory BoardCancerPartnersUK Ltd.65
Kenneth Harrap CBE, Ph.D., DSc, FRSC, SAB 13 RelationshipsMember of Advisory BoardCyclacel Pharmaceuticals, Inc.--
Stanley Kaye BSc, M.D., FRCP, FRCR, FRSE, FMedSci. 66 RelationshipsMember of Advisory BoardBiotica Technology Limited--
Lloyd Sems 27 RelationshipsMember of the Board of DirectorsSems Capital LLC43
Gregory Hradsky MBA 26 RelationshipsMember of the Board of DirectorsCostar Technologies, Inc55
Samuel Barker Ph.D. 53 RelationshipsMember of the Board of DirectorsLexicon Pharmaceuticals, Inc.72
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $0.69 USD +0.045

CYCC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CYCC.
View Industry Companies
 

Industry Analysis

CYCC

Industry Average

Valuation CYCC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.0x
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.